Le Lézard
Classified in: Health
Subject: FDA

IONETIX Partners with CIRA to Bring N-13 Ammonia to South Florida


LANSING Mich., May 16, 2022 /PRNewswire/ -- IONETIX, a leading cyclotron technology and isotope manufacturing company, is pleased to announce the FDA approval for N-13 Ammonia manufacturing at their Miami, FL location to support CIRA (Center for Imaging and Research of America). CIRA has been the leading independent imaging facility serving the greater Florida market area for nearly twenty years, priding themselves on bringing cutting edge diagnostics to the community. CIRA will be using the N-13 Ammonia manufactured by IONETIX to perform Cardiac PET imaging. Cardiac PET is used to diagnose, and risk stratify patients with coronary artery disease. Its superior image quality and ability to perform quantitative analysis is why it is considered the "gold standard" of non-invasive cardiac imaging for the detection and evaluation of CAD.

"The Top 16 Universities in the U.S. provide Cardiac PET/CT service using N-13 Ammonia, and we are proud to be the first to provide this capability to patients in South Florida." stated Rick Rippin, CIRA CEO. "In my opinion, N-13 is the gold standard in Cardiac PET and provides significant advantages over other tracers by improving image quality, improving quantification of myocardial blood flow, and enabling treadmill stress capability."

Kevin Cameron, CEO of IONETIX added, "CIRA is our 7th site approved by the FDA, and several more sites are underway. We are passionate at IONETIX about bringing our unique solution for N-13 Ammonia as a service to hospitals and outpatient office settings across the United States."

Kevin Cameron, CEO of IONETIX added, "CIRA is our 7th site approved by the FDA, and several more sites are underway. We are passionate at IONETIX about bringing our unique solution for N-13 Ammonia as a service to hospitals and outpatient office settings across the United States."

For more information, visit www.ionetix.com

About IONETIX: IONETIX is a US-based cyclotron and technology company founded in 2009. IONETIX offers turnkey N-13 Ammonia services domestically, as well as cyclotron equipment and installation services globally.

Contact:
Pete Burke
[email protected]
614-623-1383

SOURCE IONETIX


These press releases may also interest you

at 07:30
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...

at 07:30
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...

at 07:30
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...

at 07:30
-    AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)-    Data to be presented from...

at 07:28
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire. SOURCE...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...



News published on and distributed by: